Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing negative film of antigen of neutrophilic granulocyte

A technology of neutrophil and negative film, which is applied in the field of preparation of neutrophil antigen negative film, can solve the problems of high detection cost, high price, and unreachable, etc., to meet clinical needs, full cell shape, and sufficient display Effect

Inactive Publication Date: 2005-10-26
李小峰
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In the preparation process of the above-mentioned neutrophil antigen negative film, cytocentrifuge spinning is a key step. The expected effect cannot be achieved after using a domestic cytocentrifuge, and the prepared neutrophil antigen negative film is often due to cell It is in a shrunken state, and the cytoplasmic components are not fully displayed, which directly affects the observation of the results, and the price of imported cytocentrifuges is very expensive (about 100,000 yuan). Therefore, most of the commercial neutrophil antigen negatives currently used are imported products. , the price is expensive, and the detection cost is too high, which greatly restricts its routine clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Take fresh heparin anticoagulant blood from normal people, add 1% methylcellulose according to the volume ratio of 4:1, mix well and place it at room temperature for 20 minutes to allow red blood cells to settle, and collect the plasma layer rich in white blood cells.

[0027] At the same temperature, add 3ml of Ficoll-Hypaque gradient agent II with a specific gravity of 1.119 to the test tube, and then gently superimpose 3ml of Ficoll-Hypaque gradient agent I with a specific gravity of 1.077 on top of the gradient agent II.

[0028] Gently superimpose 3-4ml white blood cell plasma layer on the upper layer of the gradient agent along the tube wall, put the test tube in a horizontal centrifuge after balancing, and centrifuge at 1800rpm / min for 25 minutes. After centrifugation, the liquid can be clearly divided into 3 layers, of which the first layer is The plasma-solution I interface layer contains monocytes and platelets, the second layer is the solution-solution interfa...

Embodiment 2

[0033] Take fresh heparin anticoagulant blood from normal people, add 1% methylcellulose according to the volume ratio of 4:1, mix well, place it at room temperature for 5 minutes, centrifuge at 1000rpm / min for 2.5 minutes, let the red blood cells settle, and suck out the rich Plasma layer of white blood cells.

[0034]At the same temperature, add 3ml of Ficoll-Hypaque gradient agent II (specific gravity 1.119) to the test tube, and then gently superimpose 3ml of Ficoll-Hypaque gradient agent I (specific gravity 1.077) on the gradient agent II.

[0035] Gently superimpose 3-4ml white blood cell plasma layer on the upper layer of the gradient agent along the tube wall, put the test tube in a horizontal centrifuge after balancing, and centrifuge at 2000rpm / mm for 20 minutes. After centrifugation, the liquid can be clearly divided into 3 layers, of which the first layer is The plasma-solution I interface layer contains monocytes and platelets, the second layer is the solution-sol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to the preparation of neutral granulocyte antigen negative used to detect cytoplasmic antigen of neutrophilic granulocyte. It uses heparin anticoagulant method to subside erythrocyte and preserve leucocyte. Then it uses Ficoll-Hypaque gradient reagent to separate neutrophilic granulocyte. Then put in NaCl solution and it becomes cell suspension. Put the suspension directly on to the slide and a neutrophilic granulocyte antigen negative is ready. This negative's detectable rate is obviously greater than other domestic negatives. It has little difference with the import reagent and the cells has only one single deck and is evenly distributed. The result is easy to observe ,so it can meet clinic demand.

Description

Technical field [0001] The invention relates to a preparation method of neutrophil antigen negative film, which is used for detection of anti-neutrophil cytoplasmic antibody. Background technique [0002] Anti-neutrophil cytoplasmic antibody (anti-neutrophil cytoplasmic antibody, ANCA) is an autoantibody that targets neutrophil and monocyte cytoplasmic components. An extremely important serological diagnostic tool for primary vasculitis. Primary vasculitis mainly refers to Wegener's granulomatosis (WG), microscopic polyangiitis (MPA) and necrotizing crescentic glomerulonephritis (NCGN), and their pathogenesis is closely related to ANCA, so clinically The above-mentioned disease is called ANCA-associated vasculitis. ANCA can be divided into cANCA and pANCA according to the different fluorescent staining models. The current research believes that cANCA is more common in WG, while pANCA is often related to MPA and NCGN. They can reflect disease activity, assist diagnosis, gui...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/531
Inventor 李小峰胡学芳吕志勤侯云霞张琳李雪飞赵春阳国华
Owner 李小峰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products